REBISTART: Adherence of Patients with Multiple Sclerosis to Treatment with Subcutaneous Interferon Beta in the Context of a Patient Support Program

Abstract Introduction Treatment adherence is a critical success factor in the disease-modifying therapy (DMT) of multiple sclerosis (MS). The REBISTART study prospectively evaluated adherence in patients using components of a patient support program (PSP). Methods The 12-month non-interventional mul...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Matthias Schwab, Andrew Chan, Anna-Katharina Eser, Boris Kallmann, Dieter Pöhlau, Joachim Richter, Torsten B. Wagner, Christoph Grothe
Format:	Artigo
Jezik:	Inglês
Izdano:	Adis, Springer Healthcare 2024-03-01
Serija:	Neurology and Therapy
Teme:	Interferon beta-1a sc Subcutaneous injection Adherence Patient support program Multiple sclerosis
Online dostop:	https://doi.org/10.1007/s40120-024-00593-x
Oznake:	Označite Brez oznak, prvi označite!